Subgroup-specific target of nt-probnp level in heart failure with preserved ejection fraction

11 May 2024 (09:00 - 09:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Daisuke Sakamoto

Osaka University Graduate School of Medicine, Osaka (Japan)

7 More presentations in this session

Presentation thumbnail

Plasma proteomics, myocardial structure, and clinical outcomes in heart failure with preserved ejection fraction: insights from the NETDiamond cohort

Mr A. Razaghizad (Montreal, CA)

Abstract Slides Video

Presentation thumbnail

Diagnostic and therapeutic practices for Heart Failure with preserved ejection fraction around the world: an international survey

Professor C. Saldarriaga (Medellin, CO)

Abstract Slides Video

Presentation thumbnail

Regressive sarcomere shortening response under rate-dependent stress in a murine model of HFpEF and chronic effect of CAMKII inhibition

Mr T. Jeising (Berlin, DE)

Abstract Slides Video

Presentation thumbnail

Atypical presentation of acute pericarditis revealing pericardial sarcoidosis

Doctor C. Abdelbaki (Montivilliers, FR)

Abstract Slides Video

Presentation thumbnail

Treatment of diastolic dysfunction by targeting beta-adrenergic receptors in vivo in a murine model of cardiometabolic HFpEF

Doctor P. Sander (Berlin, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Chronic heart failure - pathophysiology and mechanisms 1

The Event

Event poster

Heart Failure 2024

11 May 2024 09:00 CET

You may be interested in

Congress Presentation

Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation

Congress Session

Biomarkers definning pathophysiology and prognosis

Congress Presentation

Utility of NT-proBNP for detecting heart failure and assessing prognosis in elderly myocardial infarction survivors: insights from the OMEMI trial

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources